{"name":"Bio-Cancer Treatment International Limited","slug":"bio-cancer-treatment-international-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBybTkzZmdYaGp1NEdoMGhrTVRJZnZSc2ZJdkV4SjdnQm8zTDV4amJPRERQZzVZVjctRklBeWVYMG9VWk5yOTMxQ05kVHVzbWY5VDlTTUxLMnJoalRadUdjVVRzUllfaXNaS1VGLVR3?oc=5","date":"2026-04-07","type":"patent","source":"KED Global","summary":"Celltrion’s biosimilar Truxima: Most prescribed blood cancer treatment in the US - KED Global","headline":"Celltrion’s biosimilar Truxima: Most prescribed blood cancer treatment in the US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBFYVd2Ty1MV3BoaGwwcFQ2anZaRUlUWmVQdWxaeDUtOU55UWt1MkJuX2xIOG9LNUFibWt3N3EwMmc3akdqUUpXX0FsdW9fdE8zWlVMUDd1ZlZnWG16akl5S25zS0h4WU1LWjFrSjZ3?oc=5","date":"2026-04-01","type":"pipeline","source":"KED Global","summary":"Curocell nears milestone with S.Korea's 1st homegrown CAR-T cancer therapy - KED Global","headline":"Curocell nears milestone with S.Korea's 1st homegrown CAR-T cancer therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AJBVV95cUxQdUhnMTFYSkFScGk3RVdIeFRXUUVmcTJ3eVNyTkEtbURaX09iQlBmZEFmdXZVVXB6SnBGMDY1d09HSjJ1a1ZWLVNxNzhmQVFVTlVNclVTRkZod0lILWNmREhsRUx6UHlCVE5qOUFwTnJoNlhHOXNNSUR1RTZaa2xIMll5Zlhzd05nUDJmZXNyNFNNbnRpQTY4MXZkQ0lrOUZKOFBJZlFHeTdaODFJd1JrRV85VnF4Qi1uc056S2lwOHNvNmVkQ1BnOC1TaWVRVV9UeGxoei16MTRrWWNTQ2M4TC1BTVVkSmdkWHlWSWxJcUhfMUVuX1pUZWg2UmdEQ2EwZVg5UUVpTENXVDhtUjRESmUtNXQzQjlnbUplcHBjbmpUYUJxOF8xRTFzeXFNUmxzNHdlcGpzZzVRdW1EUFVuTlhNT092alVuQTFGTDhMNnhuNFNFV2JaZkRJcms?oc=5","date":"2026-02-23","type":"deal","source":"Vir Biotechnology","summary":"Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - Vir Biotechnology","headline":"Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE10LWphUWUwMkc4SXl1OWlBSGY2V29FNzkzSXdUUXpRbTM2MVRReWJRRjR1QWpEY2tabWl1R2kyUFlvR3BtN1R3VjBEUGl1TWxKODgxX0Z1MUNuRmswWHFrdVNVYklHOWtfeXd2bnZn?oc=5","date":"2026-02-13","type":"trial","source":"KED Global","summary":"J Ints Bio reports promising early trial findings against lung cancer resistance mutation - KED Global","headline":"J Ints Bio reports promising early trial findings against lung cancer resistance mutation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOOTJaR013eFRQSFJnU3Zlb0ltaGRxVWJiMnVJckcxc1lGbGxSeThYckNrUDZLOG5vYXB1ajdVSFZOVnJLb2xVNFpzc0RpSEFzMllyRlRJbERzdDBMbVNKdEdNMHRPbXJTSzRycW5XQ0JLX0phZDhONVhaMFBMT2VlUmVhaVRrY1NYYW9oSjFxZWNjS1ZETHQ5NHBDOWtoN1hGV093b3drTGUxQmNMNU9rQUZrRQ?oc=5","date":"2025-12-17","type":"trial","source":"The Pharma Letter","summary":"ImmunityBio reports encouraging 3-year bladder cancer treatment data - The Pharma Letter","headline":"ImmunityBio reports encouraging 3-year bladder cancer treatment data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPQ2VMcUdZTW00cEpwcjhPcmJOWWg3em42bkNyUjJPLUg1VU5lWERuM0x6V3ZLc2pLMlNrQWtZa3ZFVGlXMW1VWnk5c2F0ZEJiSk55OGp1RERkMm5NT1JvYWpqQldZblhITjdzVHp4ZUFVSWJCWjhabmdFRnljVDN3M3VwYk1BTktxVHdTY0REX3ByaVJBNFBUSjJrak5JaWx1dHhJNnI5Yno3RldWeFVhR0FuTDFaRlZfRzJtcndSd1lJQzAwMC1xTkdub3c?oc=5","date":"2025-12-17","type":"pipeline","source":"Logistics Middle East","summary":"Mubadala Bio opens high-potency manufacturing site and debuts oncology medicines in the UAE - Logistics Middle East","headline":"Mubadala Bio opens high-potency manufacturing site and debuts oncology medicines in the UAE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxORjlaVGN4anVfQmRmR2J2enRtV2JCNldTRmE0dXFUc3ljN28zZGZBblNmVXhQY1hMcE1yLWdjNmJDRWFoZjU1anUycnFNTjVvZy1nMklfcGY3czhPc1NqOWVpZlJWVXNLaDI2Q2pBMEJmbWt4NzNhTmRNY05hM2tmOVM2SWFKNWl6?oc=5","date":"2025-09-11","type":"pipeline","source":"statnews.com","summary":"Piercing the hype around Patrick Soon-Shiong’s ‘Bioshield’ cancer treatment - statnews.com","headline":"Piercing the hype around Patrick Soon-Shiong’s ‘Bioshield’ cancer treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQLXRVRjFtRS1JN1VXV011a085Vjh3RTh3Xy12ZkFrWkc2VFVwTXNpNzZMNUpLaFBTOV9mUE8xamFtcGxBdHEwSlNxRmtUeXM1cEFhc2txYXR1akVIODFHalBPUGktVTJDRVhxcGdrTllObFMxaTFEaW14dHpyU1JMVzhiWmYtTDhlUXp2U1hsSVNJeDdsUHM1UVIzeUFYbk1SalJ4YlZpdkpSMVJpc2I0?oc=5","date":"2025-08-08","type":"regulatory","source":"Fierce Pharma","summary":"FDA restricts bluebird bio gene therapy Skysona after blood cancer reports - Fierce Pharma","headline":"FDA restricts bluebird bio gene therapy Skysona after blood cancer reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOV3MxT0pZTVBPWFhWQ3dTQi0wTk9VQ2twQkRObkZZQ1VyZHpHdWt0Z3VGai1jRE9fcl9QZDB0emJWamRVMkJWWXJEUW1rdEt0NEFaRWFFcjE4ZWM5M1NGM1BKWUhqUy1fRDh6aFFuenlXRC1uTzVQbkw5N1A3NnRPa1JoMl9uLTVxUUVISHF4NGNVVnpHQ1FQTGVNOEI1cWlUUXlydEt3dXI0Sy13Z3BURlEyc3pzYjEwdmdWZFdHdV9JRHVBTVlFRk9qNUpQUWw1Rmg2RGcyaGh0MGs?oc=5","date":"2025-07-08","type":"regulatory","source":"BioPharma APAC","summary":"ImmunityBio Secures First International Approval for ANKTIVA® in the UK for Bladder Cancer Treatment - BioPharma APAC","headline":"ImmunityBio Secures First International Approval for ANKTIVA® in the UK for Bladder Cancer Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQWEVNcVlPUjgyZ200UF9UcUdoam1qZ0IwMm1lOWpCWjJIWXVudWxqQ08zRUtvV1NqcjkxNnNCXzhabDItdWNfVWtwQXpDalFDeThwc3V4M0FCcDNzSm80Y1dKaGhTWUdKdGJxOENkLXotb3VZQnBPanktR3NjdHZQRWpMMXVrZXhsVGlhQkp3Ni1zcm5zYVBNYTRJbjNNQnRrRlYzSVNEVXQ1NVFPczk5bV9iSTFoZkJqb1ZCSmhn?oc=5","date":"2025-06-11","type":"regulatory","source":"Reuters","summary":"US FDA approves Nuvation Bio's rare lung cancer drug - Reuters","headline":"US FDA approves Nuvation Bio's rare lung cancer drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPdmJzRmJ5UU9iUmg4UkYwNWhNS1BpWGI4VkpyUkZ0bnFOOS0zbTBacVJTVUFBaTRZUFNQVDZseEdiWEFJWVotbjlRZXd1ZWVKMkZaMUthbXA2UVdyQVZUY0xtLUtuWFlMSkhvbVdJT0RzWXYzSEdKUVZ3bmlvN0xrTVRB?oc=5","date":"2025-05-01","type":"pipeline","source":"BioSpectrum Asia","summary":"The Rise of K-Biotech - BioSpectrum Asia","headline":"The Rise of K-Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNUUhybWNISExJNjd4cG5rTGZwWm1ydnltX2dBc1dBVEFDM2tCNnh6bnB5aHA0eEJGcXRHV3dfUC01dmdyY0Z1QU9YdHdkYVFTUklBd3NzNzh1Y1U3UFUzcW0wRl91SHVTRC14VkhvMnp5ekZfUUUwLVEtOVNEMURZSFhHQ0daeFlpbUZob2pvbjVEeEVUV0pTeGlrcTJBeUVfVnFJR1hGNGFnOUlVdlc2bXFWV0tVc2w2UjJhcnh0S0tGcDY1aGc?oc=5","date":"2024-10-10","type":"trial","source":"Pharmaceutical Technology","summary":"Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials - Pharmaceutical Technology","headline":"Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}